A. Jacobs

发表

preleukemia, leukemia, and lymphoid malignancies Increased circulating colony-stimulating factor-1 in patients with

E. Paietta, D. Bowen, A. Janowska-Wieczorek, 2011 .

FMS mutations in patients following cytotoxic therapy for lymphoma.

J. Whittaker, S. Ridge, H. McGlynn, 1995, Leukemia research.

Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies.

A. Belch, E. Paietta, E. Stanley, 1991, Blood.

Human preleukaemia: do we have a model?

A. Jacobs, 1987, British Journal of Cancer.

Dietary iron and haematological status in normal subjects.

A Jacobs, R. Rivlin, R H Davis, 1967, British medical journal.

Occupational and environmental exposures and myelodysplasia: a case-control study.

D. A. Stafford, A. Farrow, A. Jacobs, 1995, Leukemia research.

Iron uptake by Chang cells from transferrin, nitriloacetate and citrate complexes: the effects of iron-loading and chelation with desferrioxamine.

A. Jacobs, G. White, 1978, Biochimica et biophysica acta.

Laboratory techniques Assessment of DNA content and cell cycle distribution of erythroid and myeloid cells from bone marrow

A. Jacobs, J. Hodgetts, 2005 .

Assessment of DNA content and cell cycle distribution of erythroid and myeloid cells from bone marrow.

A. Jacobs, J. Hodgetts, T. Hoy, 1988, Journal of clinical pathology.

DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS)

R. Clark, T. Hoy, A. Jacobs, 1986, British journal of haematology.

Erythropoiesis and the Effect of Transfusion in Homozygous β-Thalassemia

I. Cavill, A. Jacobs, E. Letsky, 1978 .

The Ha-ras polymorphism in myelodysplasia and acute myeloid leukaemia.

M. Worwood, A. Jacobs, G. Carter, 1988, Leukemia research.

ras Mutations in the Myelodysplastic Syndromes

D. Oscier, D. Bowen, A. Jacobs, 1992 .

Ras Mutations in Primary Myelodysplasia and in Patients Following Cytotoxic Therapy

D. Oscier, R. Clark, D. Bowen, 1989 .

Oncogenes in the myelodysplastic syndrome.

A. Jacobs, 1989, Blood reviews.

RAS mutations in preleukaemias.

F. McCormick, D. Oscier, A. Jacobs, 1989, Haematology and blood transfusion.

Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPA.

K. Kuliczkowski, R. Darley, T. Hoy, 1995, Leukemia research.

A screen for RAS mutations in individuals at risk of secondary leukaemia due to occupational exposure to petrochemicals.

E. Zappone, A. Jacobs, R. Padua, 1995, Leukemia research.

ras Mutations in Preleukaemia, in Patients Following Cytotoxic Therapy and in Normal Subjects

J. Whittaker, A. Jacobs, R. Padua, 1991 .

Biology and pathogenesis of the myelodysplastic syndromes.

A. List, A. Jacobs, Alan F. List, 1992, Seminars in oncology.

Ferritinaemia in Leukaemia and Hodgkin's Disease

M. Worwood, A. Jacobs, F. Miller, 1973, British Journal of Cancer.

FMS mutations in myelodysplastic, leukemic, and normal subjects.

M. Worwood, D. Oscier, S. Ridge, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data.

C. Wolf, J. Hayes, J. Holmes, 1990, British Journal of Cancer.

Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic

A. Jacobs, E. Baker, A. Wong, 1992, British journal of haematology.

Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis.

M. Nathanson, G. McLaren, A. Jacobs, 1991, The Journal of laboratory and clinical medicine.

Ferritin in serum. Clinical and biochemical implications.

M. Worwood, A. Jacobs, 1975, The New England journal of medicine.

The Effects of Iron Deficiency on the Respiratory Function and Cytochrome Content of Rat Heart Mitochondria

L. Blayney, J. Muir, A. Jacobs, 1976, Circulation research.

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer.

F. Muggia, A. Hamilton, E. Andreopoulou, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

THE CLINICAL USE OF SERUM FERRITIN ESTIMATION

M. Worwood, A. Jacobs, 1975, British journal of haematology.

The Metabolism of Intravenously Administered Iron‐Dextran

I. Cavill, A. Jacobs, K. Kanakakorn, 1973, British journal of haematology.

Morphological abnormalities in lymphocyte mitochondria associated with iron-deficiency anaemia

A. Jacobs, J. Jarvis, 1974, Journal of clinical pathology.

Defect of cell-mediated immunity in patients with iron-deficiency anaemia.

D. Walker, A. Jacobs, A. E. Dolby, 1972, Lancet.

Retinoic Acid Therapy in the Myelodysplastic Syndrome

A. Jacobs, 1992 .

A Random Sample from Wales

H. Campbell, A. Jacobs, C. Entwistle, 1969, British journal of haematology.

Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes.

R. Clark, A. Jacobs, T. Hoy, 1985, Journal of clinical pathology.

Ferritin in the Serum of Normal Subjects and Patients with Iron Deficiency and Iron Overload

C. Wardrop, M. Worwood, A. Jacobs, 1972, British medical journal.

The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin

D. Bowen, A. Jacobs, Dominc Culligan, 1991, British journal of haematology.

Letter: Serum ferritin.

M. Worwood, A. Jacobs, 1976, The New England journal of medicine.

Ferritin in Blood Cells from Normal Subjects and Patients with Leukaemia

M. Worwood, J. Whittaker, A. Jacobs, 1974, British journal of haematology.

The Measurement of Reticuloendothelial Iron Release using Iron—Dextran

A. Davies, A. Jacobs, M. Beamish, 1971, British journal of haematology.

Serum ferritin and malignant tumours

A. Jacobs, 1984, Medical oncology and tumor pharmacotherapy.

The characteristics of ferritin from human tissues, serum and blood cells.

M. Worwood, W. Aherne, A. Jacobs, 1975, Clinical science and molecular medicine.

A rapid method for the detection of ferritin in serum.

A. Jacobs, M. Beamish, P. Llewellin, 1971, Journal of clinical pathology.

The Effect of Desferoxamine on Fibroblasts and Collagen Formation in Cell Cultures

R. Richards, A. Jacobs, J. Hunt, 1979, British journal of haematology.

Iron and isoferritins in iron overload.

M. Worwood, M. Wagstaff, A. Jacobs, 1982, Clinical science.

An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload

K. J. Schmidt, H. I. Glass, C. Wardrop, 1972, Journal of clinical pathology.

The reactivity of isoferritins in a labelled antibody assay.

M. Worwood, A. Jacobs, B. Jones, 1976, Immunochemistry.

Iron metabolism, sickle cell disease, and response to cyanate.

J. Graziano, M. Worwood, A. Cerami, 1975, Blood.

Ferritin Synthesis in Lymphocytes, Polymorphs and Monocytes

A. Jacobs, M. Summers, G. White, 1975, British journal of haematology.

The effect of iron stores on iron absorption in the rat: the possible role of circulating ferritin.

A. Jacobs, J. Greenman, 1975, Gut.

Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration.

M. Worwood, A. Jacobs, D. Trevett, 1975, Gut.

Ferritin in Normal Erythrocytes, Lymphocytes, Polymorphs, and Monocytes

M. Worwood, A. Jacobs, M. Summers, 1974, British journal of haematology.

IRON STORES AND IRON ABSORPTION

W. Thompson, C. S. Wood, A. Jacobs, 1973 .

The Oral Lesions of Iron Deficiency Anaemia: Pyridoxine and Riboflavin Status

I. Cavill, A. Jacobs, 1968, British Journal of Haematology.

Pyridoxine and Riboflavin Status in the Paterson — Kelly Syndrome

I. Cavill, A. Jacobs, I. A. J. Cavill, 1968, British journal of haematology.

Sideroblastic erythropoeisis in subjects with minimal or no anaemia Table Haematological datafrom six patients with sideroplastic erythropoiesis Case I Case 2 Case 3 Case 4 CaseS Case

D. Bowen, A. Jacobs, 2005 .

Pathogenesis and clinical variations in the myelodysplastic syndromes.

R. Clark, A. Jacobs, 1986, Clinics in haematology.

Red cell riboflavin in iron deficiency anaemia.

I. Cavill, A. Jacobs, 1967, Clinica chimica acta; international journal of clinical chemistry.

Gastric Acidity and Iron Absorption

D. Peters, J. Rhodes, A. Jacobs, 1966, British journal of haematology.

Gastric acid secretion in chronic iron-deficiency anaemia.

A. Jacobs, H. Campbell, C. Entwistle, 1966, Lancet.

THE IRON CONTENT OF FINGER NAILS.

D. Jenkins, A. Jacobs, 1960, The British journal of dermatology.

Internal regulation of iron absorption

I. Cavill, M. Worwood, A. Jacobs, 1975, Nature.

Iron Transport by Rat Small Intestine in Vitro: Effect of Body Iron Status

A. Jacobs, J. Howard, 1972, British journal of haematology.

The Subcellular Distribution of 59Fe in Small Intestinal Mucosa: Studies with Normal, Iron Deficient and Iron Overloaded Rats

M. Worwood, A. Jacobs, 1972, British journal of haematology.

Iron kinetics in muscle.

I. Cavill, A. Jacobs, 1971, British journal of haematology.

Non-ferritin Iron Compound in Rat Small Intestinal Mucosa during Iron Absorption

M. Worwood, A. Jacobs, A. Edwards, 1971, Nature.

The formation of iron complexes with bile and bile constituents

A. Jacobs, P. M. Miles, 1970, Gut.

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia. EORTC Leukemia Cooperative Group.

H. Gerhartz, R. Willemze, H. Zwierzina, 1992, Annals of hematology.

Annotation IRON CHELATION THERAPY FOR IRON LOADED PATIENTS

A. Jacobs, 1979 .

The Use of Chang Cells Cultured in Vitro to Evaluate Potential Iron Chelating Drugs

A. Cerami, R. Grady, A. Jacobs, 1976, British journal of haematology.

Erythroblast iron metabolism in sideroblastic marrows

P. D. Souza, A. May, A. Jacobs, 1982, British journal of haematology.

Erythropoiesis, iron stores and tissue iron exchange in man.

I. Cavill, A. Jacobs, C. Ricketts, 1979, Clinical science.

Erythroid colony growth from peripheral blood and bone marrow in polycythaemia.

A. Jacobs, P. Baines, G. Masters, 1990, Journal of clinical pathology.

The effect of chelating agents on cellular iron metabolism.

A. Jacobs, G. White, R. Bailey‐Wood, 1976, Clinical science and molecular medicine.

Refractory anaemia in the glucagonoma syndrome.

A. May, A. Jacobs, M. Jones, 1981, Clinical and laboratory haematology.

The Origin of Androgen and Estrogen in a Virilized Postmenopausal Woman With Bilateral Benign Cystic Teratomas

F. Vellios, J. C. Porter, J. Aiman, 1977, Obstetrics and gynecology.

Myelodysplasia, chemical exposure, and other environmental factors.

A. Farrow, A. Jacobs, R. West, 1989, Leukemia.

Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.

G. B. Tennant, A. Jacobs, R. Bailey‐Wood, 1986, Experimental hematology.

Extended cytogenetic follow-up and clinical progress in patients with myelodysplastic syndromes (MDS).

A. D. White, A. Jacobs, T. Hoy, 1994, Leukemia & lymphoma.

Circulating erythropoietin in patients with myelodysplastic syndromes

J. Caro, D. Bowen, A. Janowska-Wieczorek, 1989, British journal of haematology.

The effect of cytosine arabinoside on CFU-GM from patients with myelodysplastic syndrome.

R. Clark, A. Jacobs, R. Bailey‐Wood, 1987, Clinical and laboratory haematology.

Extended cytogenetic follow‐up of patients with myelodysplastic syndrome (MDS)

A. D. White, D. Culligan, A. Jacobs, 1992, British journal of haematology.

Effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on single CD34-positive hemopoietic progenitors from human bone marrow.

H. Mayani, A. Jacobs, P. Baines, 1989, International journal of cell cloning.

The effect of isoferritins on granulopoiesis

M. Worwood, G. Sala, A. Jacobs, 1986 .

DO ACIDIC ISOFERRITINS REGULATE HAEMOPOIESIS?

A. Jacobs, 1983, British journal of haematology.

Clonal lymphocytes are detectable in only some cases of MDS

J. Whittaker, A. Jacobs, R. Padua, 1992, British journal of haematology.

Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia

A. Janowska-Wieczorek, A. Jacobs, R. Padua, 1989, British journal of haematology.

Expression of the colony-stimulating factor 1 receptor in B lymphocytes.

J. Whittaker, T. Hoy, S. Ridge, 1993, Oncogene.

Growth response to cytokines of circulating myeloid progenitors from myelodysplastic patients at diagnosis and more than 600 days after diagnosis

D. Bowen, G. B. Tennant, A. Jacobs, 1991, European journal of haematology.

Enrichment of CD34 (My10)-positive myeloid and erythroid progenitors from human marrow and their growth in cultures supplemented with recombinant human granulocyte-macrophage colony-stimulating factor.

H. Mayani, A. Jacobs, P. Baines, 1988, Experimental hematology.

Primary acquired sideroblastic erythropoiesis in non-anaemic and minimally anaemic subjects.

D. Bowen, A. Jacobs, 1989, Journal of clinical pathology.

Non-dysplastic myelodysplasia?

A. Burnett, G. B. Tennant, P. Thompson, 1994, Leukemia.

A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group.

H. Gerhartz, R. Marcus, H. Zwierzina, 1994, Leukemia.

Cell-cycle progression rates and sister chromatid exchange frequencies in the bone marrow of patients with myelodysplastic syndrome and acute myeloid leukemia.

A. D. White, D. Culligan, A. Jacobs, 1992, Cancer genetics and cytogenetics.

Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome

D. Bowen, A. Jacobs, A. D. Geddes, 1990, British journal of haematology.

Haematological disorders and occupational hazards: a British Society for Haematology/Health and Safety Executive study

C. Geary, A. Jacobs, J. Osman, 1993, British journal of haematology.

Pathogenesis of Anaemia in the Myelodysplastic Syndrome

A. Jacobs, 1992 .

Circulating micromegakaryocytes in myelodysplasia.

W. Erber, D. Oscier, D. Mason, 1987, Journal of clinical pathology.

DNA index and karyotype analysis in myelodysplasia.

A. Jacobs, T. Hoy, A. D. Geddes, 1989, Journal of clinical pathology.

Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group.

H. Gerhartz, R. Marcus, H. Zwierzina, 1989, Bone marrow transplantation.

Intraluminal transport of iron from stomach to small-intestinal mucosa

A. Jacobs, P. M. Miles, 1969, British medical journal.

The biochemistry of ferritin and its clinical implications.

M. Worwood, A. Jacobs, 1975, Progress in hematology.

Turnover of 131I‐human spleen ferritin in plasma

M. Worwood, G. Owen, A. Jacobs, 1983, British journal of haematology.

The clearance of 131I-human plasma ferritin in man

M. Worwood, M. Wagstaff, A. Jacobs, 1982 .

The clearance of 131I-human plasma ferritin in man.

M. Worwood, M. Wagstaff, A. Williams, 1982, Blood.

Review article Myelodysplastic syndromes: pathogenesis, functional abnormalities, andclinical implications

A. Jacobs, 1985 .

An intracellular transit iron pool.

A. Jacobs, Allan Jacobs, 2008, Ciba Foundation symposium.

The effect of chelating agents on iron mobilization in Chang cell cultures

A. Cerami, R. Grady, A. Jacobs, 1976 .

The effect of chelating agents on iron mobilization in Chang cell cultures.

A. Cerami, R. Grady, A. Jacobs, 1976, Blood.

c-myc protein kinetics during growth and differentiation of CD34 (MY10)-positive blast cells from normal human marrow.

A. Jacobs, P. Baines, J. Hodgetts, 1989, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Nuclear c‐myc protein, maturation, and cell‐cycle status of human haemopoietic cells

A. Jacobs, P. Baines, T. Hoy, 1987, British journal of haematology.

The effects of iron deficiency on rat liver enzymes.

L. Blayney, J. Muir, A. Jacobs, 1975, British journal of experimental pathology.

Testosterone, erythropoietin and anaemia in patients with disseminated bronchial cancer.

W. O. Schreuder, A. Jacobs, W. C. Ting, 1984 .

c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.

P. Pedrazzoli, R. Watson, A. Jacobs, 1989, Cancer research.

c-myc and c-myb oncoproteins during induced maturation of human myeloid and erythroid leukaemic lines.

P. Pedrazzoli, A. Jacobs, T. Hoy, 1989, Haematology and blood transfusion.

Testosterone, erythropoietin and anaemia in patients with disseminated bronchial cancer

W. O. Schreuder, A. Jacobs, W. C. Ting, 1984, British journal of haematology.

Non-haematological effects of iron deficiency.

A. Jacobs, 1977, Clinics in haematology.

BENZENE AND LEUKAEMIA

A. Jacobs, 1989, British journal of haematology.

Benzene Haematotoxicity and Leukaemia

A. Jacobs, 1989 .

Genetic abnormalities in the myelodysplastic syndrome.

A. Jacobs, 1991, Acta haematologica Polonica.

The myelodysplastic syndrome.

A. Jacobs, 1990, European journal of cancer.

Effect of gastric juice on iron absorption in patients with gastric atrophy.

G. Owen, A. Jacobs, 1969, Gut.

A BCNU-containing Regimen, Mini-BEAM, with GM-CSF is a Safe and Effective Mobilizing Regimen Pre-stem Cell Transplantation in Lymphoma Patients.

F. Giles, A. Jacobs, S. Pepkowitz, 1997, Hematology.

Primary myelodysplastic syndrome and cancer.

R. Clark, A. Jacobs, R. West, 1987, British medical journal.

Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF)

H. Gerhartz, P. Sonneveld, R. Marcus, 1992, Infection.

Biochemical and Immunological Characterization of Ferritin from Leukaemic Cells

M. Worwood, M. Wagstaff, A. Jacobs, 1980, British journal of haematology.

Serum ferritin during unmaintained remission in acute lymphoblastic leukaemia.

A. Jacobs, C. Ricketts, D. Parry, 1978, British medical journal.

Expression of the multiple drug resistance gene (mdr‐1) and epitope masking in chronic lymphatic leukaemia

T. Tsuruo, T. Hoy, A. Jacobs, 1990, British journal of haematology.

Leukaemia Research Fund annual guest lecture 1990. Genetics lesions in preleukaemia.

A. Jacobs, 1991, Leukemia.

Role of gastric secretion in iron absorption.

A. Jacobs, P. M. Miles, 1969, Gut.

Enrichment of haemopoietic progenitor cells from the marrow of patients with myelodysplasia

A. Jacobs, P. Baines, C. Lush, 1988, British journal of haematology.

Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes

D. Bowen, A. Jacobs, P. Cotes, 1990, European journal of haematology.

Myelodysplastic syndrome in a kindred with ins(16) (p11.2)

R. Clark, A. Jacobs, K. Whittaker, 1988, Clinical genetics.

The application of X‐chromosome gene probes to the diagnosis of myeloproliferative disease

D. Oscier, A. Jacobs, R. Padua, 1989, British journal of haematology.

Effective Iron Chelation following Oral Administration of an Isoniazid‐Pyridoxal Hydrazone

A. Williams, P. Ponka, J. Humphrys, 1979, British journal of haematology.

Binding of human serum ferritin to concanavalin A.

M. Worwood, M. Wagstaff, A. Jacobs, 1979, Clinical science.

Properties of human tissue isoferritins.

M. Worwood, M. Wagstaff, A. Jacobs, 1978, The Biochemical journal.

Ferritin synthesis in normal and leukaemic leukocytes

M. Worwood, A. Jacobs, G. White, 1974, Nature.

Pyridoxal complexes as potential chelating agents for oral therapy in transfusional iron overload

A. Williams, A. Jacobs, T. Hoy, 1982, The Journal of pharmacy and pharmacology.

The Iron Content of Intestinal Epithelial Cells and Its Subcellular Distribution: Studies on Normal, Iron‐Overloaded and Iron‐Deficient Rats

M. Worwood, A. Jacobs, Veronica S. Richmond, 1972, British journal of haematology.

The Subcellular Distribution of Orally Administered 59Fe in Rat Small Intestinal Mucosa

M. Worwood, A. Jacobs, 1971, British journal of haematology.

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects

A. Jacobs, M. Summers, D. Tudway, 1979, British journal of haematology.

CARCINOMA OF THE ŒSOPHAGUS AFTER GASTRIC SURGERY

A. Jacobs, B. Lawrie, 1970 .

TISSUE CHANGES IN IRON DEFICIENCY

A. Jacobs, 1969, British journal of haematology.

Low molecular weight intracellular iron transport compounds.

A Jacobs, A. Jacobs, 1977, Blood.

Iron in biochemistry and medicine.

M. Worwood, A. Jacobs, A. Jacobs, 1974 .

Serum ferritin concentration in untreated Hodgkin's disease.

G. Canellos, J. Whittaker, P. Wiernik, 1976, British Journal of Cancer.

Gastric Factors Influencing Iron Absorption in Anaemic Patients

J. Rhodes, A. Jacobs, J. Eakins, 2009 .

Acid Secretion by the Stomach in Pernicious Anaemia *

A. Jacobs, 1958, British journal of haematology.

The use of Chang cells cultured in vitro for the investigation of cellular iron metabolism.

A. Jacobs, G. White, R. Bailey‐Wood, 1975, British journal of experimental pathology.

Binding of Serum Ferritin to Concanavalin A: Patients with Hornozygous β Thalassaemia and Transfusional Iron Overload

C. McLaren, A. Jacobs, J. Economidou, 1980, British journal of haematology.

Iron overload in Chang cell cultures: biochemical and morphological studies.

J. Humphrys, A. Jacobs, T. Hoy, 1978, British journal of experimental pathology.

Effect of phytohaemagglutinin on the synthesis and secretion of ferritin in peripheral blood lymphocytes

A. Jacobs, T. Hoy, K. Pattanapanyasat, 1988, British journal of haematology.

Iron deficiency and iron overload.

A. Jacobs, A. V. Hoffbrand, Allan Jacobs, 1985, Critical reviews in oncology/hematology.

Cellular proliferation and susceptibility to iron toxicity in iron loaded cell cultures.

A. Williams, A. Jacobs, T. Hoy, 2009, Scandinavian journal of haematology.

Ferritin Polymers and the Formation of Haemosiderin

A. Jacobs, T. Hoy, 1981, British Journal of Haematology.

Control of Iron Absorption in Hemochromatosis

M. Nathanson, A. Jacobs, D. Trevett, 1988 .

Erythropoiesis and iron metabolism in Hodgkin's disease.

I. Cavill, J. Whittaker, A. Jacobs, 1979, British Journal of Cancer.

Ferrokinetics and Erythropoiesis in Man: Red‐Cell Production and Destruction in Normal and Anaemic Subjects

I. Cavill, A. Jacobs, J. Napier, 1977, British Journal of Haematology.

The measurement of 59Fe clearance from the plasma.

I. Cavill, A. Jacobs, J. Napier, 2009, Scandinavian journal of haematology.

Iron Uptake and Ferritin Synthesis by Peripheral Blood Leucocytes from Normal Subjects and Patients with Iron Deficiency and the Anaemia of Chronic Disease

A. Jacobs, M. Summers, 1976, British journal of haematology.

Ferrokinetics and Erythropoiesis in Man: The Measurement of Effective Erythropoiesis, Ineffective Erythropoiesis and Red Cell Lifespan using 59Fe

I Cavill, C Ricketts, A Jacobs, 1975, British journal of haematology.

The use of a whole body counter for measuring bone marrow erythroid activity by profile scanning.

A. Jacobs, G. M. Owen, I. Davies, 1974, International Journal of Nuclear Medicine and Biology.

Iron kinetics in the skin of patients with iron overload.

I. Cavill, G. Staddon, A. Jacobs, 1972, The Journal of investigative dermatology.

The Measurement of Reticuloendothelial Iron Release using Iron–Dextran

A. Davies, A. Jacobs, A. Davies, 1971 .

SKIN CLEARANCE OF IRON IN NORMAL AND IRON DEFICIENT SUBJECTS

I. Cavill, A. Jacobs, 1970, British Journal of Dermatology.

Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.

S. Courtney, A. Jacobs, T. Hoy, 1988, British Journal of Cancer.

The response of intracellular and surface ferritin after T-cell stimulation in vitro.

A. Jacobs, T. Hoy, K. Pattanapanyasat, 1987, Clinical science.

Ferritin: an interim review.

A. Jacobs, 1985, Current topics in hematology.

Isoferritins in normal leucocytes

M. Worwood, A. Jacobs, B. Jones, 1983, British journal of haematology.

Erythrocyte ferritin in normal subjects and patients with abnormal iron metabolism

A. Jacobs, S. Peters, E. Fitzsimons, 1983, British journal of haematology.

Changes in the characteristics and distribution of ferritin in iron-loaded cell cultures.

A. Jacobs, T. Hoy, 1981, The Biochemical journal.

The purification and properties of ferritin from human serum.

M. Worwood, M. Wagstaff, A. Jacobs, 1976, The Biochemical journal.

METABOLIC CONSEQUENCES OF IRON OVERLOAD

A. Jacobs, 1976, British journal of haematology.

Iron Uptake and Ferritin Synthesis by Peripheral Blood Leucocytes in Patients with Primary Idiopathic Haemochromatosis

A. Jacobs, M. Summers, 1981, British journal of haematology.

The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification

A. Williams, A. Jacobs, R. Bailey‐Wood, 1985, British journal of haematology.

Ferrokinetics and Erythropoiesis in Man: An Evaluation of Ferrokinetic Measurements

I. Cavill, A. Jacobs, J. Napier, 1977, British journal of haematology.

Reduced in vitro erythroid progenitor cell growth in bronchial cancer.

A. Jacobs, P. Bentley, T. Littlewood, 1987, Journal of clinical pathology.

Anaemia in patients with myelomatosis.

I. Cavill, J. Whittaker, A. May, 1982, British Journal of Cancer.

Iron Metabolism in Hodgkin's Disease

A. Jacobs, M. Beamish, P. Jones, 1972, British Journal of Cancer.

Iron Kinetics in the Skin

I. Cavill, A. Jacobs, 1971, British journal of haematology.

Iron Turnover in the Skin

I. Cavill, A. Jacobs, M. Beamish, 1969, Nature.

The expression of cell surface ferritin by peripheral blood lymphocytes and monocytes

A. Jacobs, S. J. Cragg, T. G. Hoy, 1984, British journal of haematology.

Radioiron and erythropoiesis: methods, interpretation and clinical application.

I. Cavill, A. Jacobs, C. Ricketts, 1977, Clinics in haematology.

The Measurement of Iron Clearance from the Skin

A. Jacobs, M. R. Beamish, 1968, British journal of haematology.

Haemopoietic factors Iron absorption

A. Jacobs, 2005 .

Iron Absorption: Present State of the Art

M. Worwood, A. Jacobs, 1975 .

Absorption of 59 Fe in the rat: iron binding substances in the soluble fraction of intestinal mucosa.

M. Worwood, A. Jacobs, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

Iron absorption

A. Jacobs, 1971 .

Letter: Serum ferritin, alpha2 H globulin and malignant disease.

M. Worwood, M. Wagstaff, A. Jacobs, 1975, British Journal of Cancer.

Isoferritins in acute leukaemia.

M. Worwood, M. Wagstaff, A. Jacobs, 1977, British Journal of Cancer.

Serum ferritin concentration in early breast cancer.

R. Bulbrook, D. Wang, A. Jacobs, 1976, British Journal of Cancer.

Carbohydrates and sulphur-containing compounds in the anaemic buccal epithelium

A. Jacobs, 1961, Journal of clinical pathology.

A Random Sample from Wales

W. Waters, H. Campbell, A. Jacobs, 1969 .

A random sample from Wales. 3. Serum iron, iron binding capacity and transferrin saturation.

W. Waters, H. Campbell, A. Jacobs, 1969, British journal of haematology.

RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.

F. McCormick, D. Oscier, A. Jacobs, 1988, Leukemia.

Iron absorption and distribution in normal and scorbutic guinea pigs.

R. Hughes, A. Jacobs, P. Jones, 1972, British journal of experimental pathology.

Ferritin Concentration in Normal and Abnormal Erythrocytes Measured by Immunoradiometric Assay with Antibodies to Heart and Spleen Ferritin and Mössbauer Spectroscopy

A. Jacobs, S. Peters, S. Ofer, 1981, British journal of haematology.

Transferrin-bipyridine iron transfer mediated by haemoproteins.

A. May, A. Jacobs, A. Egyed, 1980, Biochimica et biophysica acta.

Is the mdr 1 gene relevant in chronic lymphocytic leukemia?

D. P. Bentley, J. Whittaker, J. Holmes, 1990, Leukemia.

Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes.

R. Clark, A. Jacobs, S. Peters, 1986, The New England journal of medicine.

Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.

M. Ratain, J. Vardiman, D. Golde, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma.

R. Clark, J. Whittaker, A. Jacobs, 1989, European journal of cancer & clinical oncology.

THE BUCCAL MUCOSA IN ANAEMIA

A. Jacobs, 1960, Journal of clinical pathology.

Microfilariae of Brugia pahangi in the Blood of Cats Have Variable Levels of Feline IgG on Their Sheaths

D. M. Walker, A. Jacobs, A. E. Dolby, 1989 .

Transferrin Iron, Chelatable Iron and Ferritin in Idiopathic Haemochromatosis

M. Worwood, A. Corrigall, A. Jacobs, 1974, British journal of haematology.

Phagocytosis in normal and anaemic blood

A. Jacobs, 1964, Journal of Clinical Pathology.

Globin chain synthesis ratios in sideroblastic anaemia

A. May, A. Jacobs, R. Peters, 1983, British journal of haematology.

The chelation of iron during intestinal absorption.

M. Kaye, A. Jacobs, D. Trevett, 1969, The Journal of laboratory and clinical medicine.

Iron chelation in cell cultures by two conjugates of 2,3-dihydroxybenzoic acid (2,3 -DHB).

A. Jacobs, G. White, G. Tait, 1977, Biochemical and Biophysical Research Communications - BBRC.

The development of new iron-chelating drugs. II.

J. Graziano, A. Cerami, R. Grady, 1978, The Journal of pharmacology and experimental therapeutics.

Iron chelation therapy for iron loaded patients.

A. Jacobs, 1979, British journal of haematology.

Sex differences in iron absorption

A. Jacobs, 1976, Proceedings of the Nutrition Society.

Serum Ferritin in Acute Leukaemia at Presentation and during Remission

M. Worwood, A. Jacobs, D. Parry, 1975, British medical journal.

Erythropoiesis and the effect of transfusion in homozygous beta-thalassemia.

I. Cavill, A. Jacobs, E. Letsky, 1978, The New England journal of medicine.

Enrichment of erythroblasts from human bone marrow using complement‐mediated lysis: measurement of ferritin

A. May, A. Jacobs, B. Jones, 1983, British journal of haematology.

Ascorbic acid status in iron-deficiency anaemia

I. Cavill, E. Owen, A. Jacobs, 1971, Journal of clinical pathology.

Erythrocyte ferritin concentration in patients with myelodysplastic syndromes.

A. Jacobs, S. Peters, S. May, 1985, Journal of clinical pathology.

Methylation of the DXS255 hypervariable locus 5' CCGG site may be affected by factors other than X-chromosome activation status.

J. Whittaker, A. Jacobs, R. Padua, 1992, Genomics.

Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins.

D. Bowen, A. Jacobs, P. Baines, 1990, Leukemia research.

A randomized trial of 13‐cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome

R. Clark, A. Jacobs, H. Payne, 1987, British journal of haematology.

Letter: Increased serum iron in acute leukaemia.

M. Worwood, A. Jacobs, D. Parry, 1975, British medical journal.

Clonal haemopoiesis following cytotoxic therapy for lymphoma.

R. Clark, J. Whittaker, A. Jacobs, 1993, Leukemia.

Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia.

A. Saven, L. Piro, A. Jacobs, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic Methods for Iron Status

I. Cavill, M. Worwood, A. Jacobs, 1986, Annals of clinical biochemistry.

Interferon Alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Cancer

V. Picozzi, D. Aboulafia, P. Weiden, 2000, Cancer investigation.

Erythrocyte transaminase activity in iron deficiency anaemia.

I. Cavill, A. Jacobs, 2009, Scandinavian journal of haematology.

EFFECT OF 13-cis-RETINOIC ACID ON SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME

R. Clark, A. Jacobs, C. Lush, 1987, The Lancet.

High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer

W. Nichols, P. Weiden, W. Bensinger, 1998, Bone Marrow Transplantation.

In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.

H. Mayani, D. Bowen, A. Jacobs, 1989, Leukemia.

The effect of retinoids on CFU‐GM from normal subjects and patients with myelodysplastic syndrome

A. Jacobs, R. Bailey‐Wood, S. May, 1985, British journal of haematology.

Erythrocyte transaminase activity. Effect of age, sex, and vitamin B6 supplementation.

I. Cavill, A. Jacobs, J. Hughes, 1968, The American journal of clinical nutrition.

Genetic abnormalities in myelodysplastic syndrome.

A. Jacobs, 1991, Cancer Genetics and Cytogenetics.

Effect ofgastric juice oniron absorption in patients withgastric atrophy

G. Owen, A. Jacobs, 1969 .

Iron absorption from 'Feospan' capsules and ferrous sulphate tablets B.P.

A. Jacobs, E. Fitzsimons, W. Thomson, 1984, British journal of clinical pharmacology.

The iron-binding properties of gastric juice.

A. Jacobs, P. M. Miles, 1969, Clinica chimica acta; international journal of clinical chemistry.

IRON CHELATION WITH ORAL DESFERRIOXAMINE

A. Jacobs, W. C. Ting, 1980, The Lancet.

PRIMARY ACQUIRED SIDEROBLASTIC ANAEMIA

A. Jacobs, 1986, British journal of haematology.

Serum ferritin in patients with cancer: determination with antibodies to HeLa cell and spleen ferritin.

M. Worwood, A. Jacobs, B. Jones, 1980, Clinica chimica acta; international journal of clinical chemistry.

Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid.

R. Clark, A. Jacobs, S. Smith, 1987, Journal of Clinical Pathology.

Interleukin-3 plus low-dose cytosine arabinoside for advanced myelodysplasia: a pilot study. EORTC Leukemia Group.

H. Gerhartz, H. Zwierzina, P. Fenaux, 1996, Cancer investigation.

blood and bone marrow in polycythaemia . Erythroid colony growth from peripheral

A. Jacobs, P. Baines, G. Masters, 2022 .

Interaction of ferritin with serum: implications for ferritin turnover.

M. Worwood, A. Jacobs, A. M. Covell, 1984, Clinica chimica acta; international journal of clinical chemistry.

Biochemical and immunological characteristics of ferritin from HL-60, U-937 and K-562 cell lines: implications for haemopoietic regulation.

M. Worwood, M. Wagstaff, F. Wyllie, 1984, Leukemia research.

Trial of strategy for reducing the use of laboratory tests.

F G Fowkes, A Jacobs, I. Cavill, 1986, British medical journal.

Computers in Haematology

I. Cavill, A. Jacobs, C. Ricketts, 1975 .

Serum ferritin and iron stores.

A. Jacobs, 1977, Federation proceedings.

Colony‐cluster ratio and cluster number in cultures of circulating myeloid progenitors as indicators of high‐risk myelodysplasia

D. Bowen, G. B. Tennant, A. Jacobs, 1991, British Journal of Haematology.

Iron Metabolism in the Bone Marrow

A. Jacobs, 1985 .

Effect of 5637-conditioned medium on peripheral blood granulocyte-macrophage progenitors in normal subjects and patients with the myelodysplastic syndrome.

G. B. Tennant, A. Jacobs, G. Tennant, 1989, Leukemia research.

The effect of age on iron absorption.

G. Owen, A. Jacobs, 1969, Journal of Gerontology.

The clearance of a single i.v. bolus of recombinant human erythropoietin from the serum of patients with myelodysplastic syndromes and its effects on erythropoiesis.

D. Bowen, B. Ehmer, A. Jacobs, 1991, Experimental Hematology.

The ferritin content of normoblasts and megaloblasts from human bone marrow.

T. Hoy, A. Jacobs, S. Peters, 1986, Clinical science.

A simple method for measuring iron absorption using a scintiscanner for whole-body counting.

S. Kirkman, A. Jacobs, G. M. Owen, 1967, The British journal of radiology.

Minimal diagnostic criteria for the myelodysplastic syndrome.

D. Culligan, A. Jacobs, 1992, Leukemia research.

Utilization of Iron Dextran

A. Davies, A. Jacobs, M. Beamish, 1971, British medical journal.

H. Gerhartz, M. Baccarani, F. Mandelli, 1992, Annals of Hematology.

Availability of Food Iron

A. Jacobs, D. Greenman, 1969, British medical journal.

Availability and absorption of dietary iron.

A. Jacobs, 1970, Proceedings of the Royal Society of Medicine.

Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome.

A. Jacobs, G. Tennant, 1988, Leukemia research.

Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma.

A. D. White, R. Clark, A. Jacobs, 1992, Carcinogenesis.

RAS mutations in patients following cytotoxic therapy for lymphoma.

F. McCormick, R. Clark, J. Whittaker, 1990, Oncogene.

5‐Aminolaevulinic acid synthase activity in developing human erythroblasts

G. Elder, A. May, A. Jacobs, 1988, British journal of haematology.

Myoglobin Depletion in Childhood Iron Deficiency

A. Jacobs, M. Street, T. Hoy, 1981, British journal of haematology.

Anaemia and Post-Cricoid Carcinoma

A. Jacobs, 1961, British Journal of Cancer.

The effect of isoferritins on granulopoiesis.

M. Worwood, G. Sala, A. Jacobs, 1986, Blood.

IRON ABSORPTION IN IRON-LOADING ANÆMIAS

R. Batey, A. Jacobs, 1977, The Lancet.

FURTHER INQUIRY INTO NHS EFFICIENCY

C. Birt, A. Jacobs, 1983, The Lancet.

RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia.

G. Owen, P. Thompson, S. Ridge, 1995, Leukemia.

Iron uptake and ferritin synthesis in human erythroblasts.

A. Jacobs, J. Hodgetts, T. Hoy, 1986, Clinical science.

Mitotic index and migration inhibition factor: effect of two different culture media.

D. M. Walker, A. Jacobs, A. E. Dolby, 1973, Journal of immunological methods.

Erythropoietin and the myelodysplastic syndrome.

D. Bowen, D. Culligan, A. Jacobs, 1991, Contributions to nephrology.